Trastuzumab Recruiting Phase 2 Trials for Stage IV Breast Cancer / Stage IIIB Breast Cancer / Stage IIIA Breast Cancer / HER2 Positive Breast Carcinoma / Stage IIIC Breast Cancer / Stage III Breast Cancer Treatment

RecruitingTreatment2 IdentifierTitleDrugs
NCT03179904FASN Inhibitor TVB-2640, Paclitaxel, and Trastuzumab in Treating Patients With HER2 Positive Advanced Breast Cancer
NCT02827877Copper (Cu) 64-DOTA-Trastuzumab PET Imaging in Predicting Response to Treatment With Trastuzumab and Pertuzumab Before Surgery in Patients With HER2 Positive Breast Cancer